Detalles de la búsqueda
1.
Sirtuin-2, NAD-Dependent Deacetylase, Is a New Potential Therapeutic Target for HIV-1 Infection and HIV-Related Neurological Dysfunction.
J Virol
; 97(2): e0165522, 2023 02 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36719240
2.
A minor population of macrophage-tropic HIV-1 variants is identified in recrudescing viremia following analytic treatment interruption.
Proc Natl Acad Sci U S A
; 117(18): 9981-9990, 2020 05 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32300019
3.
Methylation regulation of Antiviral host factors, Interferon Stimulated Genes (ISGs) and T-cell responses associated with natural HIV control.
PLoS Pathog
; 16(8): e1008678, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32760119
4.
TL1A-DR3 Plasma Levels Are Predictive of HIV-1 Disease Control, and DR3 Costimulation Boosts HIV-1-Specific T Cell Responses.
J Immunol
; 205(12): 3348-3357, 2020 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33177161
5.
Mechanisms of Abrupt Loss of Virus Control in a Cohort of Previous HIV Controllers.
J Virol
; 93(4)2019 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30487276
6.
Defining the HLA class I-associated viral antigen repertoire from HIV-1-infected human cells.
Eur J Immunol
; 46(1): 60-9, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26467324
7.
Immune screening identifies novel T cell targets encoded by antisense reading frames of HIV-1.
J Virol
; 89(7): 4015-9, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25589651
8.
Alternative effector-function profiling identifies broad HIV-specific T-cell responses in highly HIV-exposed individuals who remain uninfected.
J Infect Dis
; 211(6): 936-46, 2015 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25249264
9.
A human immune data-informed vaccine concept elicits strong and broad T-cell specificities associated with HIV-1 control in mice and macaques.
J Transl Med
; 13: 60, 2015 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25879820
10.
Evolution of broadly cross-reactive HIV-1-neutralizing activity: therapy-associated decline, positive association with detectable viremia, and partial restoration of B-cell subpopulations.
J Virol
; 87(22): 12227-36, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24006439
11.
Expansion of antibody secreting cells and modulation of neutralizing antibody activity in HIV infected individuals undergoing structured treatment interruptions.
J Transl Med
; 11: 48, 2013 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-23433486
12.
Plasma proteomic profiling identifies CD33 as a marker of HIV control in natural infection and after therapeutic vaccination.
EBioMedicine
; 95: 104732, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37506557
13.
Psychological stress is associated with high levels of IL-6 in HIV-1 infected individuals on effective combined antiretroviral treatment.
Brain Behav Immun
; 26(4): 568-72, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22306454
14.
Discordance between HIV-1 Population in Plasma at Rebound after Structured Treatment Interruption and Archived Provirus Population in Peripheral Blood Mononuclear Cells.
Microbiol Spectr
; 10(4): e0135322, 2022 08 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-35699458
15.
Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial.
Nat Med
; 28(12): 2611-2621, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36302893
16.
Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity.
Nat Commun
; 13(1): 6473, 2022 10 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36309514
17.
Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcome.
EBioMedicine
; 78: 103956, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35325780
18.
Definition of the viral targets of protective HIV-1-specific T cell responses.
J Transl Med
; 9: 208, 2011 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-22152067
19.
Incoming HIV virion-derived Gag Spacer Peptide 2 (p1) is a target of effective CD8+ T cell antiviral responses.
Cell Rep
; 35(6): 109103, 2021 05 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33979627
20.
Does Antigen Glycosylation Impact the HIV-Specific T Cell Immunity?
Front Immunol
; 11: 573928, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33552045